End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
42.5 CNY | +0.33% | -0.47% | -6.04% |
May. 30 | Hengrui Pharmaceuticals Gets Nod to Trial Vitiligo Drug | MT |
May. 27 | China Grants Clinical Trial Approval for Anti-Cancer Injections | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.04% | 37.19B | |
+42.60% | 739B | |
+32.34% | 598B | |
-5.74% | 353B | |
+17.79% | 318B | |
+3.37% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+6.74% | 164B |
- Stock Market
- Equities
- 600276 Stock
- News Jiangsu Hengrui Medicine Co., Ltd.
- Jiangsu Hengrui Medicine Co., Ltd.(XSSC: 600276) added to FTSE All-World Index